The zoonotic SARS-CoV-2 virus that causes COVID-19 continues to spread worldwide, with
devastating consequences. While the medical community has gained insight into the …

Children and adolescents infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the …

The Pfizer-BioNTech vaccine, currently authorized for persons aged≥ 5 years, provides a
high level of protection against severe COVID-19 in persons aged 12–18 years. Vaccine …

Importance Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C)
may inform efforts to improve health outcomes. Objective To compare clinical characteristics …

Importance Multisystem inflammatory syndrome in children (MIS-C) is associated with recent
or current SARS-CoV-2 infection. Information on MIS-C incidence is limited. Objective To …

Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that
follows benign COVID-19. We report autosomal recessive deficiencies of OAS1, OAS2, or …

Importance Coronavirus disease 2019 (COVID-19) affects the nervous system in adult
patients. The spectrum of neurologic involvement in children and adolescents is unclear …

As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there
have been increasing reports from Europe, North America, Asia, and Latin America …

COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States,
March–July 2020 | MMWR Skip directly to site content Skip directly to page options Skip directly …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has prioritized the
development of small-animal models for severe acute respiratory syndrome coronavirus 2 …